Sponsored by:

With Support From:

There are an estimated 33.2 million people worldwide who are living with HIV or AIDS, with roughly one million of those people living in the United States. Every day, over 6,800 people become infected with HIV - almost five people per minute. And, since the start of the AIDS epidemic, more than 524,000 have died of AIDS in the US alone. The statistics are truly staggering; however medical science has made great progress in recent years in the ability to successfully treat HIV infection. The so-called ‘combination therapy’ prevents HIV from mutating and spreading, allowing patients to rebuild their immune system to the same levels as the general population. To date, it represents the most significant treatment for patients suffering from HIV. Researchers are hopeful that with further study, combination therapy will prove effective in the long-term and will increase the healthy life span of more HIV-infected individuals. In this session, leading Northern California life science companies will discuss their product development efforts, as well as therapies currently on the market, and the impact they have on the treatment of HIV.

Panel Moderator:
Emily Hua
Vice President, Brand Management Practice, Campbell Alliance

Panel Speakers:
David Anderson
Regional Medical Director, Tibotec, a Johnson & Johnson subsidiary

John Flaherty, PharmD
Director of Medical Affairs, Gilead Sciences, Inc.

Marcus Conant, MD
Chief Medical Officer, Presidio Pharmaceuticals, Inc.

Rick Pesano
Senior Director, Medical Affairs, Monogram Biosciences

• When: February 26, 8:00am - 10:00am
  
• Where: Latham & Watkins LLP,140 Scott Dr., Menlo Park, CA 94025-1008 Map and Directions.
• Parking: Ample parking available at no cost in the employee lot.
• Attire: Business Attire Suggested

Registrations:
If you are an employee of a Partner or Sponsor company, please contact
Program Director, Misha Tsirulnikov to obtain your complimentary registration.

On-line reservations: CLICK HERE
Reservations by mail or fax: CLICK HERE

Early Bird Registration through February 24, 2009:
$10.00 BayBio Members
$20.00 Non-Members

On-Site Registration, February 26, 2009:
$20.00 BayBio Members
$40.00 Non-Members

• Pre-registered attendees will receive an immediate receipt/confirmation after submission.
  Please print this receipt/confirmation and bring it with you to receive your conference credentials.
  Photo ID (driver's license or passport) will be required at check-in.
• All sales are final - BayBio offers no refunds.

Please mail your event-related questions to: events@baybio.org or you can contact us via phone: 650-871-7101.
Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!